It is important to emphasize that between the groups treated with the GLP-1 RAs, the short-acting forms presented higher proportions of ARs, such as nausea, vomiting, and hypoglycemia, than the long-acting forms of GLP-1 RA [62]. The gene discussed is GCG; the disease is Hypoglycemia.